Carroll Financial Associates’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$32K Hold
201
﹤0.01% 842
2021
Q3
$33K Hold
201
﹤0.01% 858
2021
Q2
$34K Hold
201
﹤0.01% 926
2021
Q1
$32K Hold
201
﹤0.01% 882
2020
Q4
$33K Hold
201
﹤0.01% 793
2020
Q3
$31K Hold
201
﹤0.01% 760
2020
Q2
$33K Hold
201
﹤0.01% 746
2020
Q1
$26K Hold
201
﹤0.01% 729
2019
Q4
$29K Buy
201
+40
+25% +$5.49K ﹤0.01% 787
2019
Q3
$19K Sell
161
-3,520
-96% -$469K ﹤0.01% 835
2019
Q2
$518K Buy
3,681
+2,648
+256% +$365K 0.05% 208
2019
Q1
$155K Buy
1,033
+872
+542% +$125K 0.01% 364
2018
Q4
$21K Hold
161
﹤0.01% 657
2018
Q3
$25K Hold
161
﹤0.01% 648
2018
Q2
$22K Hold
161
﹤0.01% 648
2018
Q1
$21K Hold
161
﹤0.01% 657
2017
Q4
$20K Hold
161
﹤0.01% 658
2017
Q3
$20K Hold
161
﹤0.01% 654
2017
Q2
$18K Hold
161
﹤0.01% 690
2017
Q1
$16K Hold
161
﹤0.01% 714
2016
Q4
$14K Hold
161
﹤0.01% 715
2016
Q3
$16K Hold
161
﹤0.01% 701
2016
Q2
$14K Hold
161
﹤0.01% 701
2016
Q1
$14K Hold
161
﹤0.01% 693
2015
Q4
$18K Hold
161
﹤0.01% 610
2015
Q3
$15K Buy
+161
New +$19.1K ﹤0.01% 626

Other funds holding FBT

Carroll Financial Associates's FBT Position: Q4 2021 in Review

Carroll Financial Associates held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q4 2021 at 201 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #842.

Carroll Financial Associates first reported a position in FBT in Q3 2015 and has held it in 26 quarters since. The position peaked at $518K in Q2 2019. 247 funds tracked by Wall St. Rank hold FBT as of Q4 2021.

  • Carroll Financial Associates held 201 shares of First Trust NYSE Arca Biotechnology Index Fund worth $32K as of Q4 2021.
  • Carroll Financial Associates left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q4 2021.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #842 holding.
  • Carroll Financial Associates first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2015 and has held it in 26 quarters since.
  • Carroll Financial Associates's First Trust NYSE Arca Biotechnology Index Fund position peaked at $518K in Q2 2019.
  • 247 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.